心脉医疗:2025年年度净利润约5.63亿元,同比增加12.17%

Group 1 - The core viewpoint of the article highlights the significant financial performance of Xinmai Medical, with a reported revenue of approximately 1.351 billion yuan, representing a year-on-year increase of 11.96% [1] - The net profit attributable to shareholders of the listed company is approximately 563 million yuan, reflecting a year-on-year increase of 12.17% [1] - Basic earnings per share are reported at 4.65 yuan, which is a year-on-year increase of 14.25% [1] Group 2 - The article also discusses a notable shift in AI usage, indicating that China's AI invocation volume has surpassed that of the United States for the first time, leading to a surge in various sectors within the A-share market [1] - A well-known Wall Street analyst comments on China's computing power path, suggesting it disrupts traditional perceptions [1]

Endovastec-心脉医疗:2025年年度净利润约5.63亿元,同比增加12.17% - Reportify